The University of Chicago Header Logo

Connection

John Fung to Chronic Disease

This is a "connection" page, showing publications John Fung has written about Chronic Disease.
Connection Strength

0.261
  1. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002 Nov 15; 74(9):1290-6.
    View in: PubMed
    Score: 0.041
  2. Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc. 2001 Feb-Mar; 33(1-2):1486-7.
    View in: PubMed
    Score: 0.036
  3. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc. 1991 Dec; 23(6):3234-5.
    View in: PubMed
    Score: 0.019
  4. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006 Jan 12; 354(2):141-50.
    View in: PubMed
    Score: 0.013
  5. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004 May; 28(5):658-69.
    View in: PubMed
    Score: 0.011
  6. Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58. Transpl Int. 2003 Dec; 16(12):849-56.
    View in: PubMed
    Score: 0.011
  7. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
    View in: PubMed
    Score: 0.011
  8. Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc. 2002 Aug; 34(5):1968-9.
    View in: PubMed
    Score: 0.010
  9. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
    View in: PubMed
    Score: 0.009
  10. Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):319.
    View in: PubMed
    Score: 0.009
  11. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation. Transplant Proc. 2001 Feb-Mar; 33(1-2):382.
    View in: PubMed
    Score: 0.009
  12. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation. 2000 Jun 15; 69(11):2330-6.
    View in: PubMed
    Score: 0.009
  13. Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc. 1999 Aug; 31(5):2028-31.
    View in: PubMed
    Score: 0.008
  14. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc. 1998 Jun; 30(4):941-2.
    View in: PubMed
    Score: 0.008
  15. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
    View in: PubMed
    Score: 0.007
  16. Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation. 1997 Sep 15; 64(5):786-8.
    View in: PubMed
    Score: 0.007
  17. The immunolymphatic theory of chronic rejection. Transplant Proc. 1997 Sep; 29(6):2615-6.
    View in: PubMed
    Score: 0.007
  18. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997 Feb; 150(2):563-78.
    View in: PubMed
    Score: 0.007
  19. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant. 1997; 2(2):27-44.
    View in: PubMed
    Score: 0.007
  20. The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc. 1995 Feb; 27(1):67-70.
    View in: PubMed
    Score: 0.006
  21. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
    View in: PubMed
    Score: 0.005
  22. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3225-7.
    View in: PubMed
    Score: 0.005
  23. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):3005-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.